Halozyme Therapeutics
HALO
$53.98
Share price
-1.03%
Change (1 day)
8.70%
Change (1 year)
Categories
Halozyme Therapeutics (HALO) - Total debt
Total debt on the balance sheet as of March 2025 : $1.50 Billion USD
According to Halozyme Therapeutics's latest financial reports the company's total debt is $1.50 Billion USD. A company’s total debt is the sum of all current and non-current debts.
Halozyme Therapeutics - Total debt on balance sheet (from 2011 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | $1.50 B | 0.44% |
| 2023-12-31 | $1.49 B | -0.45% |
| 2022-12-31 | $1.50 B | 71.8% |
| 2021-12-31 | $0.87 B | 120.7% |
| 2020-12-31 | $0.39 B | -1.33% |
| 2019-12-31 | $0.40 B | 218.55% |
| 2018-12-31 | $0.12 B | -37.54% |
| 2017-12-31 | $0.20 B | -6.59% |
| 2016-12-31 | $0.21 B | 334.69% |
| 2015-12-31 | $49.83 M | -0.05% |
| 2014-12-31 | $49.86 M | 0.18% |
| 2013-12-31 | $49.77 M | 59.98% |
| 2012-12-31 | $31.11 M | |
| 2011-12-31 | N/A |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 MannKind Corp MNKD | $47.25 M | -96.87% | 🇺🇸 USA |
 Eli Lilly LLY | $38.51 B | 2,455.04% | 🇺🇸 USA |
 Baxter BAX | $10.30 B | 583.87% | 🇺🇸 USA |
 Pfizer PFE | $61.29 B | 3,965.87% | 🇺🇸 USA |
 Sanofi SNY | $22.78 B | 1,411.23% | 🇫🇷 France |
 Johnson & Johnson JNJ | $52.25 B | 3,366.25% | 🇺🇸 USA |